Achmea Investment Management B.V. United Therapeutics Corp Transaction History

Achmea Investment Management B.V.

$7.75 Billion
Q2 2025

A detailed history of Achmea Investment Management B.V. transactions in United Therapeutics Corp stock. As of the latest transaction made, Achmea Investment Management B.V. holds 37,814 shares of UTHR stock, worth $16.8 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares

37,814

Previous 59,180 36.1%

Holding current value

$16.8 Million

Previous $18.2 Million 40.44%

% of portfolio

0.14%

Previous 0.27%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 06, 2025	SELL	$276.47 - $328.4 $5.91 Million - $7.02 Million	-21,366 Reduced 36.1%	37,814 $10.9 Million
Q1 2025 Apr 24, 2025	BUY	$304.42 - $380.78 $6.83 Million - $8.54 Million	22,434 Added 61.05%	59,180 $18.2 Million
Q4 2024 Feb 10, 2025	BUY	$348.66 - $410.0 $4.4 Million - $5.18 Million	12,627 Added 52.35%	36,746 $13 Million
Q3 2024 Nov 12, 2024	BUY	$311.04 - $363.55 $7.5 Million - $8.77 Million	24,119 New	24,119 $8.64 Million
Q2 2023 Jul 24, 2023	SELL	$205.19 - $232.99 $19,082 - $21,668	-93 Reduced 1.89%	4,837 $1.07 Million
Q1 2023 May 04, 2023	BUY	$212.99 - $276.17 $1.05 Million - $1.36 Million	4,930 New	4,930 $1.1 Million
Q3 2020 Nov 02, 2020	SELL	$99.9 - $121.13 $87,112 - $105,625	-872 Closed	0 $0
Q1 2020 May 13, 2020	BUY	$79.39 - $115.35 $69,228 - $100,585	872 New	872 $83,000
Q3 2019 Nov 14, 2019	SELL	$74.85 - $85.99 $144,310 - $165,788	-1,928 Closed	0 $0
Q2 2019 Aug 06, 2019	SELL	$76.06 - $120.81 $764,174 - $1.21 Million	-10,047 Reduced 83.9%	1,928 $150,000
Q4 2018 Feb 14, 2019	BUY	$101.4 - $128.73 $195,499 - $248,191	1,928 Added 19.19%	11,975 $1.3 Million
Q3 2018 Nov 06, 2018	SELL	$113.81 - $129.46 $225,685 - $256,719	-1,983 Reduced 16.48%	10,047 $1.28 Million
Q2 2018 Jul 27, 2018	SELL	$101.14 - $118.31 $527,141 - $616,631	-5,212 Reduced 30.23%	12,030 $1.36 Million
Q1 2018 May 15, 2018	BUY	$107.21 - $151.94 $596,838 - $845,849	5,567 Added 47.68%	17,242 $1.93 Million
Q4 2017 Feb 12, 2018	SELL	$118.58 - $151.28 $537,523 - $685,752	-4,533 Reduced 27.97%	11,675 $1.73 Million
Q3 2017 Nov 09, 2017	BUY	$114.6 - $136.81 $101,535 - $121,213	886 Added 5.78%	16,208 $1.9 Million
Q2 2017 Aug 29, 2017	BUY	N/A	15,322	15,322 $1.99 Million

Others Institutions Holding UTHR

# of Institutions

751

Shares Held

43.4M

Call Options Held

340K

Put Options Held

318K

View Full List

About UNITED THERAPEUTICS Corp

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $20.3B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

More about UTHR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Achmea Investment Management B.V., based on Form 13F filings with the SEC.

News

Stay updated on Achmea Investment Management B.V. with notifications on news.

Account

Achmea Investment Management B.V. United Therapeutics Corp Transaction History